Lancashire and South Cumbria
Formulary
Formulary
12 Ear, nose and oropharynx
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
12-02-03 Nasal Staphylococci
| Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin® |
|
Formulary
|
| Nasal cream Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% |
 MHRA: Medical Device Alert |
|
Links
- LSCMMG: Gastroenterology Biologics Pathway
- LSCMMG: Primary Care Constipation Guidelines
- MHRA alert: Anaphylaxis risk with chlorhexidine
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Medical Device Alert
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people